Impact of maze procedure in patients with severe tricuspid regurgitation and persistent atrial fibrillation

被引:4
|
作者
Park, Ilkun [1 ]
Jeong, Dong Seop [1 ,5 ]
Park, Sung-Ji [2 ,6 ]
Ahn, Joong Hyun [3 ]
Kim, Jihoon [2 ]
Kim, Eun Kyoung [2 ]
Sung, Kiick [1 ]
Kim, Wook Sung [1 ]
Park, Pyo Won [4 ]
机构
[1] Sungkyunkwan Univ, Sch Med, Dept Thorac & Cardiovasc Surg, Seoul, South Korea
[2] Sungkyunkwan Univ, Heart Vasc Stroke Inst, Cardiovasc Imaging Ctr, Sch Med,Dept Internal Med, Seoul, South Korea
[3] Sungkyunkwan Univ, Biostat & Clin Epidemiol Ctr, Samsung Med Ctr, Sch Med, Seoul, South Korea
[4] Incheon Sejong Hosp, Dept Thorac & Cardiovasc Surg, Incheon, Gyeonggi Do, South Korea
[5] Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Dept Thorac & Cardiovasc Surg, 81 Irwon-ro, Seoul 06351, South Korea
[6] Sungkyunkwan Univ, Heart Vasc Stroke Inst, Cardiovasc Imaging Ctr, Sch Med,Samsung Med Ctr, 81 Irwon Ro, Seoul 06351, South Korea
来源
关键词
tricuspid regurgitation; atrial fibrillation; maze procedure; SINUS RHYTHM RESTORATION; SURGICAL ABLATION; IV PROCEDURE; HEART-FAILURE; RISK-FACTORS; PREDICTORS; RECOMMENDATIONS; OUTCOMES; NODE; DYSFUNCTION;
D O I
10.1016/j.jtcvs.2021.10.057
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Patients with severe tricuspid regurgitation and persistent atrial fibrilla-tion may not be good candidates for maze procedure due to preoperative atrial remodeling and various comorbidities. We attempted to evaluate the rhythm and clinical outcomes of maze procedure in these patients.Methods: Patients with severe tricuspid regurgitation and persistent atrial fibrilla-tion who underwent tricuspid valve surgery between January 1994 and December 2017 at a single tertiary center were analyzed. The primary end point was sinus rhythm restoration. The key secondary end point was major adverse cardiovascular and cerebrovascular event rate, which is the composite event of stroke, cardiac death, major bleeding, and readmission for heart failure. Propensity score matching analysis was used.Results: A total of 388 patients underwent tricuspid valve surgery, and among them 172 patients (44%) underwent concomitant maze procedure. The maze group had sinus rhythm restoration rate of 56% in 9 years. Further, in the matched cohort, the maze group had higher freedom from major adverse cardiovascular and cerebrovascular event rate at 10 years than the nonmaze group (55.6% vs 36.2%; P = .047). Preoperative left atrial diameter (hazard ratio, 1.022; 95% CI, 1.0121.033; P < .001) and right atrial diameter (hazard ratio, 1.012; 95% CI, 1.003-1.022; P = .013) were independent risk factors for failure of sinus rhythm.Conclusions: Maze procedure in severe tricuspid regurgitation and persistent atrial fibrillation had acceptable rates of sinus rhythm restoration and reduced major adverse cardiovascular and cerebrovascular events in the long-term. Careful patient selection considering preoperative atrial diameters is needed to enhance maze success rate and long-term clinical outcomes. (J Thorac Cardiovasc Surg 2023;166:478-88)
引用
收藏
页码:478 / +
页数:16
相关论文
共 50 条
  • [21] Predictors for the Development of Severe Tricuspid Regurgitation with Anatomically Normal Valve in Patients with Atrial Fibrillation
    Najib, Mohammad Q.
    Vinales, Karyne L.
    Vittala, Satya S.
    Challa, Suresh
    Lee, Howard R.
    Chaliki, Hari P.
    ECHOCARDIOGRAPHY-A JOURNAL OF CARDIOVASCULAR ULTRASOUND AND ALLIED TECHNIQUES, 2012, 29 (02): : 140 - 146
  • [22] Atrial Fibrillation, Tricuspid Regurgitation, and Pacemaker
    Bonapace, Stefano
    Marinelli, Alessio
    Costa, Alessandro
    Trachanas, Konstantinos
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (16)
  • [23] A Hybrid Maze Procedure for Long-Standing Persistent Atrial Fibrillation
    Cox, James L.
    Churyla, Andrei
    Malaisrie, S. Chris
    Duc Thinh Pham
    Kruse, Jane
    Kislitsina, Olga N.
    McCarthy, Patrick M.
    ANNALS OF THORACIC SURGERY, 2019, 107 (02): : 610 - 618
  • [24] Impact of atrial mitral and tricuspid regurgitation on atrial fibrillation recurrence after ablation
    Nakamura, Keijiro
    Takagi, Takahito
    Kogame, Norihiro
    Asami, Masako
    Toyoda, Yasutake
    Enomoto, Yoshinari
    Hara, Hidehiko
    Moroi, Masao
    Noro, Mahito
    Sugi, Kaoru
    Nakamura, Masato
    JOURNAL OF ELECTROCARDIOLOGY, 2021, 66 : 114 - 121
  • [25] Impact of ablation duration on rhythm outcome after concomitant maze procedure using cryoablation in patients with persistent atrial fibrillation
    Dong Seop Jeong
    Ji Hoon You
    Chang-Seok Jeon
    Pyo Won Park
    Kiick Sung
    Wook Sung Kim
    Young Tak Lee
    Journal of Cardiothoracic Surgery, 12
  • [26] Impact of ablation duration on rhythm outcome after concomitant maze procedure using cryoablation in patients with persistent atrial fibrillation
    Jeong, Dong Seop
    You, Ji Hoon
    Jeon, Chang-Seok
    Park, Pyo Won
    Sung, Kiick
    Kim, Wook Sung
    Lee, Young Tak
    JOURNAL OF CARDIOTHORACIC SURGERY, 2017, 12
  • [27] COMBINED TREATMENT OF MITRAL REGURGITATION AND ATRIAL-FIBRILLATION WITH VALVULOPLASTY AND THE MAZE PROCEDURE
    MCCARTHY, PM
    COSGROVE, DM
    CASTLE, LW
    WHITE, RD
    KLEIN, AL
    AMERICAN JOURNAL OF CARDIOLOGY, 1993, 71 (05): : 483 - 486
  • [28] Clinical performance and exercise hemodynamics in patients with severe secondary tricuspid regurgitation and chronic atrial fibrillation
    Jensen, Jesper K.
    Clemmensen, Tor S.
    Frederiksen, Christian A.
    Schofer, Joachim
    Andersen, Mads J.
    Poulsen, Steen H.
    BMC CARDIOVASCULAR DISORDERS, 2021, 21 (01)
  • [29] Incidence and Predictors of Severe Tricuspid Regurgitation in Atrial Fibrillation Patients Without Structural Heart Disease
    Cho, Min Soo
    Cha, Myung-Jin
    Nam, Gi-Byoung
    Choi, Kee-Joon
    Kim, Jun
    AMERICAN JOURNAL OF CARDIOLOGY, 2023, 203 : 288 - 294
  • [30] Clinical performance and exercise hemodynamics in patients with severe secondary tricuspid regurgitation and chronic atrial fibrillation
    Jesper K. Jensen
    Tor S. Clemmensen
    Christian A. Frederiksen
    Joachim Schofer
    Mads J. Andersen
    Steen H. Poulsen
    BMC Cardiovascular Disorders, 21